Ioana E. Braicu
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.
Journal: Cell reports. Medicine
Published: November 28, 2025
Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancer.
Journal: Archives of gynecology and obstetrics
Published: January 30, 2025
Transforming treatment paradigms: Focus on personalized medicine for high-grade serous ovarian cancer.
Journal: CA: a cancer journal for clinicians
Published: January 11, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 15, 2024
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer.
Journal: Neoplasia (New York, N.Y.)
Published: June 22, 2023
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
Journal: Journal of ovarian research
Published: March 23, 2023
Complete Response to Immune Checkpoint Inhibition in a Platinum Resistant Primary Ovarian Cancer Patient With Lynch Syndrome: A Case Report and Review of the Literature.
Journal: Anticancer research
Published: December 12, 2022
tRNA-derived small RNA 3'U-tRFValCAC promotes tumour migration and early progression in ovarian cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 11, 2022
Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer.
Journal: Frontiers in oncology
Published: August 08, 2022
Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: July 29, 2020
miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients.
Journal: International journal of cancer
Published: February 27, 2020
Last Updated: 09/26/2026